Latest Shareholder Interests News

Leo Lithium has received the final US$177.6 million payment from Ganfeng for its Goulamina stake and is advancing multiple lithium hard rock acquisitions, aiming to relist on the ASX.

Barton Gold Holdings has completed the acquisition rights for the Wudinna Gold Project, adding 279,000 ounces of gold to its South Australian portfolio and raising its total resources to 2.14 million ounces. The deal, approved by Cobra Resources shareholders, positions Barton for regional growth pending final tenement transfers.

NOVONIX has entered a multi-tranche funding agreement with Yorkville Advisors to raise up to US$100 million through convertible debentures, supporting its Riverside facility build-out and commercial production ramp-up.

Papyrus Australia has fully impaired its investments in its Egyptian joint ventures PPYEg and EBFC, citing lack of returns and governance issues ahead of its 2025 audited results.

BKI Investment Company posted a solid financial performance for FY2025 with a 1% increase in dividends and introduced a neutralised Dividend Reinvestment Plan to maintain capital neutrality. Despite modest portfolio underperformance against major ETFs, BKI continues to offer an attractive dividend yield amid shifting market dynamics.

M3 Mining Limited reports steady progress at its Edjudina Gold and Victoria Bore Copper projects, alongside significant corporate restructuring and the sale of its energy subsidiary.

Strickland Metals plans a capital return by distributing 1.2 billion Gateway Convertible Preference Shares to its shareholders, significantly reducing its stake and reshaping ownership. The move awaits shareholder approval and hinges on conditions tied to an asset sale agreement.

Openn Negotiation Ltd moves forward with a creditor-approved recapitalisation plan following voluntary administration, while its shares remain suspended on the ASX.

Openn Negotiation Ltd has entered voluntary administration following a failed $2.5 million capital raise, with its shares suspended on the ASX. Administrators have secured funding to maintain operations while pursuing a sale or recapitalisation.

Lumos Diagnostics has locked in a A$5 million secured loan facility to support working capital as it advances toward FDA CLIA waiver for its FebriDx® test, complementing a landmark US distribution deal.

Pacific Edge Limited (ASX – PEB) has announced a securities purchase plan (SPP) aiming to raise up to NZD 5 million, contingent on shareholder approval of a prior NZD 16 million placement. The move is designed to bolster working capital amid ongoing growth initiatives.

Platinum Capital Limited has released detailed worked examples for its proposed scheme of arrangement, outlining a special dividend payout and the exchange ratio for shares into ETF units. The final dividend value and unit allocation will be confirmed closer to the scheme implementation date.